# A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

> **NCT04733989** · — · COMPLETED · sponsor: **GAP Innovations, PBC** · enrollment: 1002 (actual)

## Conditions studied

- Alzheimer Disease
- Alzheimer Disease, Early Onset
- Mild Cognitive Impairment
- Memory Loss
- Memory Disorders
- Memory Impairment

## Interventions

- **OTHER:** Biomarker Data Collection

## Key facts

- **NCT ID:** NCT04733989
- **Lead sponsor:** GAP Innovations, PBC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-21
- **Primary completion:** 2022-11-11
- **Final completion:** 2022-11-11
- **Target enrollment:** 1002 (ACTUAL)
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04733989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04733989, "A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04733989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*